INVA Competitors & Alternatives
Compare Innoviva Inc with similar stocks in the same industry
Biotechnology
INVA
Main Stock$18.97
Tradestie Score
50
Market Cap
$1.15B
P/E Ratio
8.1
Revenue Growth
0.0%
Analyst Upside
+83.4%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RCUS
Arcus Biosciences, Inc.
|
$17.77
|
$1.43B | - | 61 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$11.50
|
$1.42B | - | 42 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$9.54
|
$1.35B | - | 58 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$25.85
|
$1.32B | - | 48 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$16.65
|
$1.29B | - | 38 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$26.20
|
$1.29B | - | 54 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.12
|
$1.29B | - | 67 | Compare |
|
ZYME
Zymeworks Inc.
|
$26.47
|
$1.28B | 54.8 | 48 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.06
|
$1.27B | - | 54 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
More INVA Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry